Advertisement

Supportive Care in Cancer

, Volume 27, Issue 12, pp 4401–4433 | Cite as

Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses

  • Laurence Leysen
  • Astrid Lahousse
  • Jo Nijs
  • Nele Adriaenssens
  • Olivier Mairesse
  • Sergei Ivakhnov
  • Thomas Bilterys
  • Eveline Van Looveren
  • Roselien Pas
  • David BeckwéeEmail author
Review Article
  • 218 Downloads

Abstract

Background

Breast cancer remains the most frequently diagnosed malignancy among women worldwide, with rising incidence numbers. In Belgium, one out of eight women will be diagnosed with breast cancer. Fortunately, 80% of those breast cancer patients will still be alive 10 years after diagnosis due to improvements in screening and treatment strategies. However, an important portion of the breast cancer survivors (BCS) will face side effects, such as sleep disturbances, long after treatment ends. It has been demonstrated that untreated insomnia in BCS negatively impacts mood, physical symptoms, pain sensitivity, fatigue, and quality of life. Furthermore, insomnia is increasingly considered an independent risk factor for future depression in BCS. The importance of understanding sleep disturbances in cancer populations has been highlighted and recognized as warranting further research. Therefore, the purpose of this systematic review was to determine the prevalence and the risk factors for the development of sleep disturbances in BCS.

Methods

PubMed, Web of Science, and PEDro were systematically screened for studies encompassing data regarding the prevalence or risk factors of sleep disturbances in BCS. If possible, meta-analyses were performed. Subgroup analyses were undertaken based on the methodological quality, study design, type of sleep disturbance, and the use of a measurement tool with strong psychometric properties to investigate significant heterogeneity (I2 > 50%) across studies.

Results

A total of 27 studies were found eligible. The pooled estimate for sleep disturbances prevalence is 0.40 (95% confidence interval (CI) = [0.29–0.52], I2 = 100%, p < 0.00001) and ranged from 0.14 (95% CI = [0.04–0.24]) to 0.93 (95% CI = [0.91–0.95]). Subgroup analyses did not reduce the heterogeneity among studies. Meta-analyses were performed for seven risk factors. Significant differences for the odds of developing sleep disturbances were found for hot flashes (pooled OR (ORp) 2.25, 95% CI = [1.64–3.08], I2 = 0%, p = 0.90), race (ORp 2.31, 95% CI = [1.56–3.42], I2 = 0%, p = 0.47), and menopause (ORp 1.84, 95% CI = [1.11–3.06], I2 = 0%, p = 0.70). After withdrawing the studies that did not rely on the use of a measurement tool with strong psychometric properties, pain (ORp 2.31, 95% CI = [1.36–3.92], I2 = 27%, p = 0.25), depressive symptoms (ORp 3.20, 95% CI [2.32–4.42], I2 = 0%, p = 0.63), and fatigue (ORp 2.82, 95% CI = [1.98–4.02], I2 = 0%, p = 0.60) became significant as well, with a substantial decrease of heterogeneity.

Conclusion

Prevalence for sleep disturbances ranged from 0.14 to 0.93 with the vast majority of the studies investigating insomnia and sleep-wake disturbances. High heterogeneity makes it difficult to draw firm conclusions. Pain, depressive symptoms, hot flashes, fatigue, non-Caucasian race, and menopausal status were significantly associated with increased odds for developing sleep disturbances.

Keywords

Insomnia Sleep disturbances Breast cancer survivors Risk factors Determinants Prevalence 

Notes

Compliance with ethical standards

Conflict of interest

The authors have full control of all data acquired from included manuscripts and agree to allow the journal to review the data if requested.

References

  1. 1.
    Fitzmaurice C et al (2016) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA OncolGoogle Scholar
  2. 2.
    Coleman MP, Quaresma M, Berrino F, Lutz JM, de Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL, CONCORD Working Group (2008) Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9(8):730–756CrossRefPubMedGoogle Scholar
  3. 3.
    Roth T (2007) Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med 3(5 Suppl):S7–S10PubMedPubMedCentralGoogle Scholar
  4. 4.
    American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders-IV-TR. American Psychiatric Association, Washington, DCGoogle Scholar
  5. 5.
    Colten H, Altevogt B (2006) Sleep disorders and sleep deprivation: an unmet public health problem, vol 2007. National Academies Press, Washington, DCGoogle Scholar
  6. 6.
    Janz NK et al (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health 16(9):1348–1361CrossRefGoogle Scholar
  7. 7.
    Reinsel RA, Starr TD, O'Sullivan B, Passik SD, Kavey NB (2015) Polysomnographic study of sleep in survivors of breast Cancer. J Clin Sleep Med 11(12):1361–1370CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Jim HS et al (2013) Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy. Health Psychol 32(7):768–774CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Daley M et al (2009) The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 32(1):55–64PubMedPubMedCentralGoogle Scholar
  10. 10.
    Morin CM (1993) Insomnia: psychological assessment and management. Guilford PressGoogle Scholar
  11. 11.
    Savard J et al (2001) Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 24(5):583–590CrossRefPubMedGoogle Scholar
  12. 12.
    Hoffman KE et al (2009) Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med 169(14):1274–1281CrossRefPubMedGoogle Scholar
  13. 13.
    Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D (2013) Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum 40(1):35–42CrossRefPubMedGoogle Scholar
  14. 14.
    Waters EA et al (2013) Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients. Ann Behav Med 45(1):57–68CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Berrett-Abebe J et al (2015) Exploring the relationship between fear of cancer recurrence and sleep quality in cancer survivors. J Psychosoc Oncol 33(3):297–309CrossRefPubMedGoogle Scholar
  16. 16.
    Irvine DM, Vincent L, Graydon JE, Bubela N (1998) Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs 21(2):127–135CrossRefPubMedGoogle Scholar
  17. 17.
    Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR (2010) Prevalence, demographics, and psychological associations of sleep disruption in patients with Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program. J Clin Oncol 28(2):292–298CrossRefPubMedGoogle Scholar
  18. 18.
    Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34CrossRefPubMedGoogle Scholar
  19. 19.
    Office of Cancer Survivorship, NCI About cancer survivorship research: survivorship definitions. 2012. Available from: http://cancercontrol.cancer.gov/ocs/researcher_factsheet.pdf
  20. 20.
    Elmagarmid A et al (2014) Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews. In: Evidence-informed public health: opportunities and challenges. Abstracts of the 22nd Cochrane Colloquium. Wiley, HyderabadGoogle Scholar
  21. 21.
    Green, S., et al., Chapter 1: what is a systematic review. Cochrane handbook for systematic reviews of interventions version, 2008. 5(0)Google Scholar
  22. 22.
    Dahl AA et al (2011) Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations. Sleep Med 12(6):584–590CrossRefPubMedGoogle Scholar
  23. 23.
    Kim SH et al (2008) Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manag 35(6):644–655CrossRefGoogle Scholar
  24. 24.
    Klyushnenkova EN, Sorkin JD, Gallicchio L (2015) Association of obesity and sleep problems among breast cancer survivors: results from a registry-based survey study. Support Care Cancer 23(12):3437–3445CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Otte JL et al (2010) Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manag 39(3):535–547CrossRefGoogle Scholar
  26. 26.
    Modesti PA et al (2016) Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One 11(1):e0147601CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    McPheeters ML et al (2012) Closing the quality gap: revisiting the state of the science (vol. 3: quality improvement interventions to address health disparities). Evid Rep Technol Assess (Full Rep) (208.3):1–475Google Scholar
  28. 28.
    Higgins JP et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Deeks JJ, Higgins J, Altman DG (2008) Analysing data and undertaking meta-analyses. In: Cochrane handbook for systematic reviews of interventions: Cochrane book series, pp 243–296CrossRefGoogle Scholar
  30. 30.
    Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327–333CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Desai K, Mao JJ, Su I, DeMichele A, Li Q, Xie SX, Gehrman PR (2013) Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer 21(1):43–51CrossRefPubMedGoogle Scholar
  32. 32.
    Ahn SH et al (2007) Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol 18(1):173–182CrossRefPubMedGoogle Scholar
  33. 33.
    Alfano CM, Lichstein KL, Vander Wal GS, Smith AW, Reeve BB, McTiernan A, Bernstein L, Baumgartner KB, Ballard-Barbash R (2011) Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res Treat 130(1):243–254CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Arraras JI et al (2016) Quality of life in long-term premenopausal early-stage breast cancer survivors from Spain. Effects of surgery and time since surgery. J Buon 21(5):1090–1098Google Scholar
  35. 35.
    Berger AM et al (2012) Usual and worst symptom severity and interference with function in breast cancer survivors. J Support Oncol 10(3):112–118CrossRefPubMedGoogle Scholar
  36. 36.
    Couzi RJ, Helzlsouer KJ, Fetting JH (1995) Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 13(11):2737–2744CrossRefPubMedGoogle Scholar
  37. 37.
    Forsythe L et al (2012) Daytime sleepiness and sleep duration in long-term cancer survivors and non-cancer controls: results from a registry-based survey study. Support Care Cancer 20(10):2425–2432CrossRefPubMedGoogle Scholar
  38. 38.
    Gonzalez BD, Lu Q (2018) Sleep disturbance among Chinese breast cancer survivors living in the USA. Support Care Cancer 26(6):1695–1698CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Heins MJ et al (2013) For which health problems do cancer survivors visit their general practitioner? Eur J Cancer 49(1):211–218CrossRefPubMedGoogle Scholar
  40. 40.
    Kluthcovsky A et al (2012) Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on health-related quality of life. Support Care Cancer 20(8):1901–1909CrossRefGoogle Scholar
  41. 41.
    Lee ES et al (2011) Health-related quality of life in survivors with breast cancer 1 year after diagnosis compared with the general population a prospective cohort study. Ann Surg 253(1):101–108CrossRefPubMedGoogle Scholar
  42. 42.
    Lowery-Allison AE et al (2017) Sleep problems in breast cancer survivors 1-10 years posttreatment. Palliat Support Care:1–10Google Scholar
  43. 43.
    Marinac CR, Nelson SH, Flatt SW, Natarajan L, Pierce JP, Patterson RE (2017) Sleep duration and breast cancer prognosis: perspectives from the Women's healthy eating and living study. Breast Cancer Res Treat 162(3):581–589CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R (2011) Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res 71(3):136–141CrossRefPubMedGoogle Scholar
  45. 45.
    Palmer SC et al (2016) Symptoms, unmet need, and quality of life among recent breast cancer survivors. J Community Support Oncol 14(7):299–306CrossRefGoogle Scholar
  46. 46.
    Schultz PN et al (2005) Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J Clin Nurs 14(2):204–211CrossRefPubMedGoogle Scholar
  47. 47.
    Servaes P, Verhagen S, Bleijenberg G (2002) Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 13(4):589–598CrossRefPubMedGoogle Scholar
  48. 48.
    Taylor TR et al (2012) Understanding sleep disturbances in African-American breast cancer survivors: a pilot study. Psycho-Oncology 21(8):896–902CrossRefPubMedGoogle Scholar
  49. 49.
    Yang EJ, Kim BR, Shin HI, Lim JY (2012) Use of the international classification of functioning, disability and health as a functional assessment tool for breast cancer survivors. J Breast Cancer 15(1):43–50CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Zucca AC, Boyes AW, Linden W, Girgis A (2012) All's well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types. J Pain Symptom Manag 43(4):720–731CrossRefGoogle Scholar
  51. 51.
    Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146(5):1387–1394CrossRefPubMedGoogle Scholar
  52. 52.
    Fiorentino L, Ancoli-Israel S (2006) Insomnia and its treatment in women with breast cancer. Sleep Med Rev 10(6):419–429CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19(3):895–908CrossRefPubMedGoogle Scholar
  54. 54.
    Palesh O, Aldridge-Gerry A, Zeitzer JM, Koopman C, Neri E, Giese-Davis J, Jo B, Kraemer H, Nouriani B, Spiegel D (2014) Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep 37(5):837–842CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Galiano-Castillo N, Arroyo-Morales M, Ariza-Garcia A, Fernández-Lao C, Fernández-Fernández AJ, Cantarero-Villanueva I (2017) Factors that explain the cancer-related insomnia. Breast J 23(4):387–394CrossRefPubMedGoogle Scholar
  56. 56.
    Jansson-Frojmark M, Lindblom K (2008) A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. J Psychosom Res 64(4):443–449CrossRefPubMedGoogle Scholar
  57. 57.
    Morphy H et al (2007) Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 30(3):274–280PubMedGoogle Scholar
  58. 58.
    Johnson EO, Roth T, Breslau N (2006) The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res 40(8):700–708CrossRefPubMedGoogle Scholar
  59. 59.
    Ohayon MM, Roth T (2003) Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37(1):9–15CrossRefPubMedGoogle Scholar
  60. 60.
    Carpenter JS, Elam JL, Ridner SH, Carney PH, Cherry GJ, Cucullu HL (2004) Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31(3):591–5598CrossRefPubMedGoogle Scholar
  61. 61.
    Ford DE, Kamerow DB (1989) Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? Jama 262(11):1479–1484CrossRefPubMedGoogle Scholar
  62. 62.
    Ell K et al (2005) Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecological cancer. J Clin Oncol Off J Am Soc Clin Oncol 23(13):3052CrossRefGoogle Scholar
  63. 63.
    Forsythe LP, Alfano CM, George SM, McTiernan A, Baumgartner KB, Bernstein L, Ballard-Barbash R (2013) Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 137(2):617–630CrossRefPubMedGoogle Scholar
  64. 64.
    Anders CK et al (2009) Breast cancer before age 40 years. Semin Oncol 36(3):237–249CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E (2007) Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from international breast Cancer study group trials V and VI. Eur J Cancer 43(11):1646–1653CrossRefPubMedGoogle Scholar
  66. 66.
    Rapkin AJ (2007) Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol 196(2):97–106CrossRefPubMedGoogle Scholar
  67. 67.
    Kronenberg F (1990) Hot flashes: epidemiology and physiologya. Ann N Y Acad Sci 592(1):52–86CrossRefPubMedGoogle Scholar
  68. 68.
    Morales L, Neven P, Timmerman D, Christiaens MR, Vergote I, van Limbergen E, Carbonez A, van Huffel S, Ameye L, Paridaens R (2004) Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anti-Cancer Drugs 15(8):753–760CrossRefPubMedGoogle Scholar
  69. 69.
    Abrahams HJG, Gielissen MFM, Verhagen CAHHVM, Knoop H (2018) The relationship of fatigue in breast cancer survivors with quality of life and factors to address in psychological interventions: a systematic review. Clin Psychol Rev 63:1–11CrossRefPubMedGoogle Scholar
  70. 70.
    Rumble ME, Keefe FJ, Edinger JD, Affleck G, Marcom PK, Shaw HS (2010) Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast Cancer survivors: a daily process analysis. Sleep 33(11):1501–1509CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Dudley KA, Patel SR (2016) Disparities and genetic risk factors in obstructive sleep apnea. Sleep Med 18:96–102CrossRefPubMedGoogle Scholar
  72. 72.
    Beatty DL, Hall MH, Kamarck TA, Buysse DJ, Owens JF, Reis SE, Mezick EJ, Strollo PJ, Matthews KA (2011) Unfair treatment is associated with poor sleep in African American and Caucasian adults: Pittsburgh SleepSCORE project. Health Psychol 30(3):351–359CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Hall M, Bromberger J, Matthews K (1999) Socioeconomic status as a correlate of sleep in African-American and Caucasian women. Ann N Y Acad Sci 896(1):427–430CrossRefPubMedGoogle Scholar
  74. 74.
    Jüni P et al (2002) Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 31(1):115–123CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Laurence Leysen
    • 1
    • 2
  • Astrid Lahousse
    • 2
  • Jo Nijs
    • 1
    • 2
    • 3
  • Nele Adriaenssens
    • 2
    • 4
  • Olivier Mairesse
    • 5
    • 6
  • Sergei Ivakhnov
    • 2
  • Thomas Bilterys
    • 1
    • 2
    • 7
  • Eveline Van Looveren
    • 1
    • 7
  • Roselien Pas
    • 1
    • 2
  • David Beckwée
    • 2
    • 8
    Email author
  1. 1.Pain in Motion International Research Group
  2. 2.Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education and PhysiotherapyVrije Universiteit BrusselBrusselsBelgium
  3. 3.Department of Physical Medicine and PhysiotherapyUniversity Hospital BrusselsBrusselsBelgium
  4. 4.Department of OncologyUniversity Hospital BrusselsBrusselsBelgium
  5. 5.Experimental and Applied Psychology, Faculty of Psychology and Educational SciencesVrije Universiteit BrusselBrusselsBelgium
  6. 6.Sleep Laboratory and Unit for ChronobiologyBrugmann University HospitalBrusselsBelgium
  7. 7.Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health SciencesGhent UniversityGhentBelgium
  8. 8.Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health SciencesUniversity of AntwerpWilrijkBelgium

Personalised recommendations